First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors
暂无分享,去创建一个
J. Desai | J. Tabernero | M. Brown | R. Dienstmann | S. Evers | J. Cebon | B. Lestini | U. Lassen | F. Su | K. Schostack | Weijiang Zhang | V. Méresse | F. Boisserie | V. Méresse